.Merck beats revenues requirements, raises purchases overview on strong need for best medications like Keytruda CNBCMerck & Co. (MRK US) Beats Earnings Forecasts as Keytruda Purchases Increase BloombergMerck Sell: Pharma Titan Posts Strong End Results, Yet Overview Drops Short Client's Business DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck defeats income and sales expectations among Keytruda strength, yet offers blended full-year expectation MarketWatch.